Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Bleeding due to acquired dysfibrinogenemia as the initial presentation of multiple myeloma.

Siddiq N, Bergstrom C, Anderson LD Jr, Nagalla S.

BMJ Case Rep. 2019 Jul 17;12(7). pii: e229312. doi: 10.1136/bcr-2019-229312.

PMID:
31320370
2.

Coagulation Testing in Patients Taking Direct Oral Anticoagulants: A Teachable Moment.

Siddiq N, Nagalla S, Choi SH.

JAMA Intern Med. 2019 Jun 24. doi: 10.1001/jamainternmed.2019.1799. [Epub ahead of print] No abstract available.

PMID:
31233085
3.

Myeloproliferative neoplasms (MPNs) - Part 1: An overview of the diagnosis and treatment of the "classical" MPNs.

Fowlkes S, Murray C, Fulford A, De Gelder T, Siddiq N.

Can Oncol Nurs J. 2018 Oct 1;28(4):262-268. doi: 10.5737/23688076284262268. eCollection 2018 Fall.

4.

Myeloproliferative neoplasms (MPNs) - Part 2: A nursing guide to managing the symptom burden of MPNs.

Fowlkes S, Murray C, Fulford A, De Gelder T, Siddiq N.

Can Oncol Nurs J. 2018 Oct 1;28(4):276-281. doi: 10.5737/23688076284276281. eCollection 2018 Fall.

5.

Néoplasies myéloprolifératives (NMP) – Partie 2 : Guide infirmier sur la conduite à tenir devant les symptômes de NMP.

Fowlkes S, Murray C, Fulford A, De Gelder T, Siddiq N.

Can Oncol Nurs J. 2018 Oct 1;28(4):282-287. doi: 10.5737/23688076284282287. eCollection 2018 Fall. French. No abstract available.

PMID:
31148829
Free PMC Article
6.

Néoplasies myéloprolifératives – Partie 1 : survol du diagnostic et du traitement des NMP « classiques ».

Fowlkes S, Murray C, Fulford A, De Gelder T, Siddiq N.

Can Oncol Nurs J. 2018 Oct 1;28(4):269-275. doi: 10.5737/23688076284269275. eCollection 2018 Fall. French. No abstract available.

PMID:
31148817
Free PMC Article
7.

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes.

McNamara CJ, Panzarella T, Kennedy JA, Arruda A, Claudio JO, Daher-Reyes G, Ho J, Siddiq N, Devlin R, Tsui H, Su J, Stockley T, Sukhai M, Kanwar N, Chan S, Maze D, Schimmer A, Schuh A, Sibai H, Viswabandya A, Yee K, Minden MD, Kamel-Reid S, Gupta V.

Blood Adv. 2018 Oct 23;2(20):2658-2671. doi: 10.1182/bloodadvances.2018021469.

8.

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy.

Spiegel JY, McNamara C, Kennedy JA, Panzarella T, Arruda A, Stockley T, Sukhai M, Thomas M, Bartoszko J, Ho J, Siddiq N, Maze D, Schimmer A, Schuh A, Sibai H, Yee K, Claudio J, Devlin R, Minden MD, Kamel-Reid S, Gupta V.

Blood Adv. 2017 Sep 8;1(20):1729-1738. doi: 10.1182/bloodadvances.2017009530. eCollection 2017 Sep 12.

9.

Prevalence and presentation of tuberculosis among hemodialysis patients in Khartoum, Sudan.

Banaga AS, Siddiq NK, Alsayed RT, Babiker R, Elmusharaf K.

Saudi J Kidney Dis Transpl. 2016 Sep-Oct;27(5):992-996. doi: 10.4103/1319-2442.190873.

10.

Perinatal mortality contributors in singleton gestation.

Ghazi A, Ali T, Jabbar S, Siddiq NM, Lata S, Noren S, Mansoor M.

J Coll Physicians Surg Pak. 2009 Nov;19(11):711-3. doi: 11.2009/JCPSP.711713.

PMID:
19889268

Supplemental Content

Loading ...
Support Center